(MedPage Today) -- The FDA warned today that use of proton pump inhibitors -- including popular brands such as Nexium, Prilosec, and Prevacid -- may increase the risk of Clostridium difficile-associated diarrhea.
proton pump inhibitorsICAAC: PPIs May be Tied to C. diff Diarrhea (CME/CE)MedPage Today Infectious Disease Sun, 09/18/2011 - 11:24
CHICAGO (MedPage Today) -- Hospitalized patients on proton pump inhibitors (PPIs) have an increased risk of diarrhea associated with Clostridium difficile (CDAD), Japanese researchers reported. ACG: PPI Use Linked to C. difficile Risk (CME/CE, with audio)MedPage Today Infectious Disease Thu, 10/21/2010 - 09:02
SAN ANTONIO (MedPage Today) -- Treatment with proton pump inhibitors (PPIs) may significantly increase the risk of Clostridium difficile diarrhea, according to a meta-analysis of 21 published studies. DDW: PPI Use Linked to C. Difficile Diarrhea (CME/CE)MedPage Today Infectious Disease Fri, 05/07/2010 - 16:56
NEW ORLEANS (MedPage Today) -- Use of proton pump inhibitors (PPIs) may predispose patients to infection with Clostridium difficile, results of a meta-analysis suggested. DDW: PPI, Surgery Offer Simlar GERD Control (CME/CE)MedPage Today Surgery Fri, 05/07/2010 - 07:15
NEW ORLEANS (MedPage Today) -- Proton Pump Inhibitors (PPIs) are just as effective as laparoscopic surgery for patients with chronic gastroesophageal reflux disease, results of a multicenter clinical trial suggest. Cogent trial shows lack of adverse interaction between clopidogr...EurekAlert! - Medicine and Health Wed, 09/23/2009 - 22:00
(Cardiovascular Research Foundation) Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors, did not lead to adverse events, as some prior studies had suggested. Tags:
|
